Breaking News

AI for breast cancer detection growing faster than trust in the results

May 29, 2025
Do you know a stellar young scientist? We invite you to nominate them for STAT Wunderkinds, our annual contest to celebrate early-career researchers who are not yet independent scientists or program leaders.
Adobe

STAT+ | AI-based mammography is here, and it has a trust problem

Despite FDA clearance, AI breast cancer detection tools face skepticism from some radiologists who are slow to trust new mammogram screening tools.

By Katie Palmer


STAT+ | HHS cancels nearly $600 million Moderna contract on vaccines for flu pandemics

Move is a blow to the country's capacity to respond to a pandemic as no other flu vaccine production method can match the speed of Moderna's mRNA platform.

By Helen Branswell and Matthew Herper


STAT+ | A rare disease drug is rejected, even as the FDA talks about new approval pathway

The FDA withheld its endorsement of a drug for Barth syndrome, but decided it may be possible for Stealth BioTherapeutics to pursue accelerated approval.

By Ed Silverman



Vivodyne co-founder and CEO Andrei Georgescu and Chief Operating Officer Julie O'Shaughnessy are seen here with the system the company designed.
Courtesy Julie O'Shaughnessy

STAT+ | As the FDA and NIH eschew animal testing, startup raises $40 million for lab-grown organs

FDA, NIH push to reduce or replace animal testing expected to spur growth in organoid firms; Dan Huh's Vivodyne announces $40 million investment.

By Allison DeAngelis


Opinion: How we beat anti-vaccination bills in North Dakota

We defeated expanding vaccine exemptions and reducing mandates in North Dakota by sitting down and listening.

By Josh Gryniewicz and Sandy Tibke


Opinion: The U.S. medical system is overrun with 'numerical epidemics'

The criteria for being declared sick is rapidly being broadened, instigating epidemics of diseases across the medical horizon.

By Andy Lazris and Alan Roth


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments